Logo
x

Search category

Subscribe Now

Final Recommendation

NICE Publishes Final Recommendation for Almirall's Ilumetri (tildrakizumab) to Treat Moderate-To-Severe Plaque Psoriasis in Adults

NICE Publishes Final Recommendation for Almirall's Ilumetri (tildrakizumab) to Treat Moderate-To-Severe Plaque Psoriasis in Adults

  • April 19, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.